Where does Lonza Biologics PLC. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Lonza Biologics PLC. ranks #20,027 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Lonza Biologics PLC. hold?

Lonza Biologics PLC. holds 14 US utility patents granted between 2015 and 2023, spanning 10 technology areas.

What is Lonza Biologics PLC.'s Innovation Score?

Lonza Biologics PLC. has an Innovation Score of 32.0 out of 100 (40th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

Is Lonza Biologics PLC.'s patent grant rate increasing or decreasing?

Lonza Biologics PLC.'s recent grant velocity is -73% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Lonza Biologics PLC.'s patents?

Lonza Biologics PLC.'s patents average 14.6 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Lonza Biologics PLC. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Lonza Biologics PLC.

Q: What technology areas does Lonza Biologics PLC. focus on?

Lonza Biologics PLC.'s top technology area is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media) with 9 patents, ranking #1,126 of 4,144 assignees active in that subclass. Grants appear in 10 CPC subclasses total.

USPTO PatentsView assignee record - 14 granted patents across 10 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Lonza ranks #20,027 of 49,997 tracked US assignees by granted-patent volume, with 14 patents across 10 technology areas.

#20,027
of 49,997 US assignees by volume: 40th percentile
by Innovation Score (32.0/100): 14.6
avg claims per patent: -73%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R20027 · Foreign Corporation #20,027 · 14 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 14 grants
MID-PACK #20,027/49,997
PHOTO-FINISH Locus OIL IP
CPC-FOCUS C12N · 10 areas
INNOV-THIN 32.0/100
CLAIMS-RICH 14.6 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -73% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Locus OIL IP Company, LLC (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Lonza’s 32.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 9.4 pts (29%) Velocity 2.7 pts (8%) Breadth 11.2 pts (35%) Claim depth 8.8 pts (27%)

Qualcomm Incorporated · highest

85
Lonza Biologics · this assignee

32
3D Lighting… · lowest

7

What this shows Lonza's Innovation Score is 32.0/100 (40th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Lonza?

Each dot is one of Lonza’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Lonza’s own 14.6 claims/patent is ABOVE the 7.9 median for these volume peers. More thorough claims than most filers at this scale, not just more of them.

Lonza vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Lonza's grants concentrate

Lonza Biologics PLC. is a focused PatentsView assignee: 10 CPC subclasses with 64.3% of grants classified under C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media). Peak complete grant year is 2017 (4 grants) versus a trough of 1 in 2015. By volume, Lonza sits between Locus OIL IP Company, LLC and Lumon Invest OY.

Lonza's three-year grant acceleration

Lonza Biologics PLC. shows 2 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Locus OIL IP

14
Logan Clutch

14
Logue AND PTY AS…

14
Lontra

14
LPW Technology

14
Lucky Brand Indus…

14
Luft Industrie

14
Lumon Invest OY

14
Lonza Biologics ◀

14

What this shows Lonza holds 14 patents at rank #20,010, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Lonza

By rank, the assignees closest to #20,010 in granted patent volume.

Leaders in C12N (Microorganisms OR Enzymes)

Other assignees with the most granted patents in Lonza's primary technology class.

Lonza's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

32 40th percentile higher than 40% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Lonza Biologics PLC. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	1	7.1%
2016	1	7.1%
2017	4	28.6%
2018	1	7.1%
2019	4	28.6%
2020	1	7.1%
2022	1	7.1%
2023	1	7.1%

Which technologies does Lonza Biologics PLC. patent most?

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 9

C07K - Peptides 7

C12M - Apparatus FOR Enzymology OR MICROBIOLOGY; Apparatus FOR Culturing Microorganisms FOR Producing Biomass, FOR Growing Cells OR FOR Obtaining Fermentation OR Metabolic Products, i.e. Bioreactors OR Fermenters 4

C12P - Fermentation OR Enzyme-using Processes TO Synthesise A Desired Chemical Compound OR Composition OR TO Separate Optical Isomers From A Racemic Mixture 3

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 2

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 2

C12Y - Enzymes 1

B01D - Separation 1

H01J - Electric Discharge Tubes OR Discharge Lamps 1

B01L - Chemical OR Physical Laboratory Apparatus FOR General USE 1

Top 10 of 10 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Lonza Biologics PLC.'s patent record in context - here's where to go next.

Lonza Biologics PLC.'s lead technology class is C12N (Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media), 64.3% of its portfolio - see every assignee active in that class. Explore C12N
Ranked #20,027 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Lonza Biologics PLC. against Locus OIL IP Company, LLC, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 32.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.